SCHEMBL2983002

SCHEMBL2983002

CCOC(=O)/C(C#N)=C\c1ccc(Cl)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.71
MAPT P10636 7/20 0.71
KDM4E B2RXH2 5/20 0.71
PKM P14618 1/20 0.64
HTT P42858 1/20 0.64
KMT2A Q03164 4/20 0.63
MEN1 O00255 3/20 0.63
L3MBTL1 Q9Y468 2/20 0.63
TDP1 Q9NUW8 2/20 0.63
NPC1 O15118 1/20 0.63
MAPK1 P28482 1/20 0.63
CASP3 P42574 1/20 0.63
RAB9A P51151 1/20 0.63
SENP8 Q96LD8 1/20 0.63
SENP7 Q9BQF6 1/20 0.63
SENP6 Q9GZR1 1/20 0.63
PDCD1 Q15116 1/20 0.60
CD274 Q9NZQ7 1/20 0.60
CRHBP P24387 1/20 0.60
CRHR2 Q13324 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2576359 1.00 ALDH1A1 (0.71) ALDH1A1MAPTKDM4EPKMHTT
SCHEMBL988798 1.00 ALDH1A1 (0.71) ALDH1A1MAPTKDM4EPKMHTT
SCHEMBL4317761 0.92 ALDH1A1 (0.81) ALDH1A1MAPTKDM4EPKMHTT
SCHEMBL2139678 0.92 ALDH1A1 (0.81) ALDH1A1MAPTKDM4EPKMHTT
SCHEMBL2139676 0.92 ALDH1A1 (0.81) ALDH1A1MAPTKDM4EPKMHTT
SCHEMBL21457264 0.89 TP53 (0.57) ALDH1A1MAPTKDM4EPKMHTT
SCHEMBL21457267 0.89 TP53 (0.57) ALDH1A1MAPTKDM4EPKMHTT
SCHEMBL20278911 0.88 ALDH1A1 (0.74) ALDH1A1MAPTKDM4EPKMHTT
SCHEMBL8998886 0.88 ALDH1A1 (0.74) ALDH1A1MAPTKDM4EPKMHTT
SCHEMBL8998890 0.88 ALDH1A1 (0.74) ALDH1A1MAPTKDM4EPKMHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060085922-A1 Oxidizing composition comprising at least one electrophilic monomer and at least one non-benzoquinone oxidant L'OREAL S.A. (FR) 2006-04-27 US claimed
US-20120156270-A1 METHOD FOR SMOOTHING OUT THE SKIN BY FILLING IN RECESSED PORTIONS L'OREAL (FR) 2012-06-21 US disclosed
US-20120156270-A1 METHOD FOR SMOOTHING OUT THE SKIN BY FILLING IN RECESSED PORTIONS L'OREAL (FR) 2012-06-21 US disclosed
US-20120156270-A1 METHOD FOR SMOOTHING OUT THE SKIN BY FILLING IN RECESSED PORTIONS L'OREAL (FR) 2012-06-21 US disclosed
WO-2011003771-A2 METHOD FOR SMOOTHING OUT THE SKIN BY FILLING IN RECESSED PORTIONS L'OREAL (FR) 2011-01-13 WO disclosed
US-20100172858-A1 COSMETIC COMPOSITION COMPRISING AT LEAST ONE POLYMER OBTAINED FROM A DIELECTROPHILIC MONOMER L'OREAL S.A. (FR) 2010-07-08 US disclosed
US-20100172858-A1 COSMETIC COMPOSITION COMPRISING AT LEAST ONE POLYMER OBTAINED FROM A DIELECTROPHILIC MONOMER L'OREAL S.A. (FR) 2010-07-08 US disclosed
US-20100172858-A1 COSMETIC COMPOSITION COMPRISING AT LEAST ONE POLYMER OBTAINED FROM A DIELECTROPHILIC MONOMER L'OREAL S.A. (FR) 2010-07-08 US disclosed
EP-2124874-A2 COSMETIC COMPOSITION COMPRISING AT LEAST ONE POLYMER OBTAINED FROM A DIELECTROPHILIC MONOMER L'Oreal (FR) 2009-12-02 EP disclosed
US-7621966-B2 Cosmetic composition comprising at least one pigment and/or at least one filler surface-treated beforehand with at least one organic agent and at least one electrophilic monomer L'OREAL S.A. (FR) 2009-11-24 US disclosed
US-20060276515-A1 Soluble Epoxide Hydrolase Inhibitors and Methods of Using Same BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2006-12-07 US disclosed
WO-2006121719-A2 SOLUBLE EPOXIDE HYDROLASE INHIBITORS AND METHODS OF USING SAME BOEHRINGER INGELHEIM INTERNATIONAL, GMBH (DE) 2006-11-16 WO disclosed
US-20060233731-A1 Use, for the cosmetic treatment of keratin materials, of a film-forming composition comprising an electrophilic monomer and a non-silicone polymer, conferring a soft coating L'OREAL S.A. (FR) 2006-10-19 US disclosed
US-20060179587-A1 Dyeing composition comprising a specific pigment and at least one electrophilic monomer L'OREAL S.A. (FR) 2006-08-17 US disclosed
US-20060115445-A1 Compositions for treating keratin materials comprising electrophilic monomers and liquid crystal agents L'OREAL S.A. (FR) 2006-06-01 US disclosed
US-20060088493-A1 Composition and process for the cosmetic treatment of keratin materials based on electrophilic monomers and non-silicone polymers L'OREAL S.A. (FR) 2006-04-27 US disclosed
US-20060088488-A1 Dyeing composition comprising a mixture of at least one pigment and at least one electrophilic monomer L'OREAL S.A. (FR) 2006-04-27 US disclosed
US-20060083706-A1 Haircare composition comprising at least one electrophilic monomer and micro- or nanoparticles of at least one solid lubricant L'OREAL S.A. (FR) 2006-04-20 US disclosed
US-20060083762-A1 Uses of compositions comprising electrophilic monomers and micro-particles or nanoparticles L'OREAL S.A. (FR) 2006-04-20 US disclosed
US-20060078522-A1 Composition for treating keratin materials comprising at least one electrophilic monomer and at least one salt L'OREAL S.A. (FR) 2006-04-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (11 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060088493-A1 Composition and process for the cosmetic treatment of keratin materials based on electrophilic monomers and non-silicone polymers KRT18, CUTA, MARK1 ALDH1A1 3552/4885MAPT 366/4885KDM4E 421/4885
US-20060083762-A1 Uses of compositions comprising electrophilic monomers and micro-particles or nanoparticles KRT18, PRKDC, ACP1 ALDH1A1 828/4885MAPT 355/4885KDM4E 3279/4885
US-20060115445-A1 Compositions for treating keratin materials comprising electrophilic monomers and liquid crystal agents KRT18, PRKDC, CUTA ALDH1A1 1395/4885MAPT 133/4885KDM4E 2386/4885
US-20100172858-A1 COSMETIC COMPOSITION COMPRISING AT LEAST ONE POLYMER OBTAINED FROM A DIELECTROPHILIC MONOMER KRT18, DSG1, DSC1 ALDH1A1 320/4885MAPT 721/4885KDM4E 1488/4885
US-20060085922-A1 Oxidizing composition comprising at least one electrophilic monomer and at least one non-benzoquinone oxidant KRT18, GPX4, NOX4 ALDH1A1 303/4885MAPT 2098/4885KDM4E 1870/4885
US-20060233731-A1 Use, for the cosmetic treatment of keratin materials, of a film-forming composition comprising an electrophilic monomer and a non-silicone polymer, conferring a soft coating KRT18, CUTA, VIM ALDH1A1 3279/4885MAPT 360/4885KDM4E 564/4885
US-20060083706-A1 Haircare composition comprising at least one electrophilic monomer and micro- or nanoparticles of at least one solid lubricant MITF, CUTA, NACA ALDH1A1 43/4885MAPT 865/4885KDM4E 4498/4885
US-20060276515-A1 Soluble Epoxide Hydrolase Inhibitors and Methods of Using Same EPHX1, EPHX2, NCEH1 ALDH1A1 385/4885MAPT 4778/4885KDM4E 2114/4885
US-20060088488-A1 Dyeing composition comprising a mixture of at least one pigment and at least one electrophilic monomer KRT18, IK, DDR1 ALDH1A1 155/4885MAPT 248/4885KDM4E 4287/4885
US-20060078522-A1 Composition for treating keratin materials comprising at least one electrophilic monomer and at least one salt KRT18, DSG1, DSC1 ALDH1A1 1453/4885MAPT 215/4885KDM4E 2607/4885
US-20120156270-A1 METHOD FOR SMOOTHING OUT THE SKIN BY FILLING IN RECESSED PORTIONS EPAS1, PGF, PASK ALDH1A1 4610/4885MAPT 4165/4885KDM4E 1404/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.